Diamond Therapeutics is a psychedelic pharmaceutical company. We're
developing safe, FDA, EMA and Health Canada approved therapies for
neuropsychiatric conditions, starting with sub-perceptual psilocybin-based
medicines that have the potential to deliver greater impact than current
first-line treatments.